Differential immunohistochemical localization of desmosomal plaque‐related proteins in non‐small‐cell lung cancer

Immunohistochemistry is a highly valuable and widely used tool in the subtyping of lung carcinomas. The aim of this study was to identify markers for the differential diagnosis of non‐small‐cell carcinomas.

[1]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[2]  K. Green,et al.  Regulation of desmosome assembly and adhesion. , 2004, Seminars in cell & developmental biology.

[3]  D. Sivam,et al.  Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis , 2000, The Laryngoscope.

[4]  Lin Huan,et al.  Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer , 2010 .

[5]  M. Rode,et al.  Plakophilins 1a and 1b: widespread nuclear proteins recruited in specific epithelial cells as desmosomal plaque components , 1997, Cell and Tissue Research.

[6]  Y. Joo,et al.  Expression of E-Cadherin and Catenins in Early Gastric Cancer , 2002, Journal of clinical gastroenterology.

[7]  D. Postma,et al.  Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus , 2006, Journal of Clinical Pathology.

[8]  C. Dawson,et al.  Desmosomes: a role in cancer? , 2007, British Journal of Cancer.

[9]  Jeffrey W. Clark,et al.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.

[10]  C. Sima,et al.  Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens , 2011, Modern Pathology.

[11]  Brett J. Roberts,et al.  Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. , 2010, The Journal of investigative dermatology.

[12]  R. Moll,et al.  Desmosomal plakophilin 2 as a differentiation marker in normal and malignant tissues. , 1999, Differentiation; research in biological diversity.

[13]  H. Kurzen,et al.  The distribution of the desmosomal protein, plakophilin 1, in human skin and skin tumors. , 1997, The Journal of investigative dermatology.

[14]  Thomas J. Smith,et al.  美国临床肿瘤学会Ⅳ期非小细胞肺癌化疗的临床实践指南更新 , 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[15]  L. Trojan,et al.  Tumorigenesis and Neoplastic Progression Desmosomal Plakophilins in the Prostate and Prostatic Adenocarcinomas Implications for Diagnosis and Tumor Progression , 2010 .

[16]  W. Franke,et al.  Complete amino acid sequence of the epidermal desmoglein precursor polypeptide and identification of a second type of desmoglein gene. , 1991, European journal of cell biology.

[17]  A. Nagafuchi.  Molecular architecture of adherens junctions. , 2001, Current opinion in cell biology.

[18]  Ansgar Schmidt,et al.  Differential expression of desmosomal plakophilins in various types of carcinomas: correlation with cell type and differentiation. , 2006, Human pathology.

[19]  M. Hatzfeld.  Plakophilins: Multifunctional proteins or just regulators of desmosomal adhesion? , 2007, Biochimica et biophysica acta.

[20]  Giuseppe Pelosi,et al.  p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma , 2012, Modern Pathology.

[21]  A. Schmidt,et al.  Plakophilins--hard work in the desmosome, recreation in the nucleus? , 2005, European journal of cell biology.

[22]  H. Sugihara,et al.  Dynamic alteration of the E‐cadherin/catenin complex during cell differentiation and invasion of undifferentiated‐type gastric carcinomas , 2005, The Journal of pathology.

[23]  R. Moll,et al.  The Desmosomal Plaque Proteins of the Plakophilin Family , 2010, Dermatology research and practice.

[24]  M. Rode,et al.  Plakophilin 3--a novel cell-type-specific desmosomal plaque protein. , 1999, Differentiation; research in biological diversity.

[25]  U. Nuber,et al.  Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells. , 1996, European journal of cell biology.

[26]  R. Hynes,et al.  Plakoglobin: A protein common to different kinds of intercellular adhering junctions , 1986, Cell.

[27]  M. Mahoney,et al.  Decreased Plakophilin-1 Expression Promotes Increased Motility in Head and Neck Squamous Cell Carcinoma Cells , 2007, Cell communication & adhesion.

[28]  A. Nicholson,et al.  Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. , 2013, Archives of pathology & laboratory medicine.

[29]  Silvana Papagerakis,et al.  Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. , 2003, Human pathology.

[30]  W. Travis,et al.  Desmoglein 3 as a prognostic factor in lung cancer. , 2007, Human pathology.

[31]  C. Haffner,et al.  The Function of Plakophilin 1 in Desmosome Assembly and Actin Filament Organization , 2000, The Journal of cell biology.

[32]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  A. Kargı,et al.  The Diagnostic Value of TTF-1, CK 5/6, and p63 Immunostaining in Classification of Lung Carcinomas , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[34]  R. D. Lynch,et al.  The tight junction: a multifunctional complex. , 2004, American journal of physiology. Cell physiology.

[35]  U. Pastorino,et al.  &Dgr;Np63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[36]  Yusuke Nakamura,et al.  Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. , 2005, Cancer research.

[37]  U. Nuber,et al.  The widespread human desmocollin Dsc2 and tissue-specific patterns of synthesis of various desmocollin subtypes. , 1995, European journal of cell biology.

[38]  R. Bremer,et al.  A 6-Antibody Panel for the Classification of Lung Adenocarcinoma Versus Squamous Cell Carcinoma , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[39]  Rafael Rosell,et al.  Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer , 2011, International journal of cancer.

[40]  T. Schmid,et al.  Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact. , 2012, American journal of clinical pathology.

[41]  S. Kaya,et al.  Desmoglein-3 and Napsin A Double Stain, a Useful Immunohistochemical Marker for Differentiation of Lung Squamous Cell Carcinoma and Adenocarcinoma From Other Subtypes , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[42]  Anna Spreafico,et al.  The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[44]  L. Tanoue.  Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer , 2010 .

[45]  Johan Vansteenkiste,et al.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Yang Xue-ning.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011 .

[47]  Guzin G Demirag,et al.  Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers , 2011, Diagnostic pathology.

[48]  W. Travis.  WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .

[49]  L. Godsel,et al.  Plakophilins: multifunctional scaffolds for adhesion and signaling. , 2009, Current opinion in cell biology.

[50]  W. Franke,et al.  Molecular Diversity of Plaques of Epithelial‐Adhering Junctions , 2000, Annals of the New York Academy of Sciences.

[51]  W. Franke,et al.  Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque , 1996, The Journal of cell biology.

[52]  Sanjay Mukhopadhyay,et al.  Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6 , 2011, The American journal of surgical pathology.

[53]  W. H. Evans,et al.  Gap junctions: structure and function (Review) , 2002, Molecular membrane biology.

[54]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.